Status:
ACTIVE_NOT_RECRUITING
Trans-Rectal Ultrasound of the Female Pelvis for Real-Time MRI-US Fusion Based Needle Tracking
Lead Sponsor:
Duke University
Collaborating Sponsors:
Eigen
Conditions:
Uterine Cancer
Eligibility:
FEMALE
18-90 years
Brief Summary
The purpose of this study is to utilize transrectal ultrasound (TRUS) images of the intact and post-hysterectomy female pelvis in order to provide feasibility information for a Magnetic Resonance Imag...
Eligibility Criteria
Inclusion
- Histologically proven invasive primary squamous, adenosquamous, or adenocarcinoma of the uterine cervix, (recurrent or medically inoperable) uterine adenocarcinoma.
- Treatment plan must include curative-intent definitive radiation that includes brachytherapy treatments with or without concurrent chemotherapy
- Adults ≥ 18 years of age
- ECOG Performance Status 0-2
Exclusion
- Patients with active rectal bleeding or rectal ulcer
Key Trial Info
Start Date :
February 7 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 11 2025
Estimated Enrollment :
7 Patients enrolled
Trial Details
Trial ID
NCT05977621
Start Date
February 7 2024
End Date
December 11 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Duke Cancer Center
Durham, North Carolina, United States, 27710